HPV OncoTect™ E6, E7 mRNA Kit by IncellDx, Inc.

Manufacturer IncellDx, Inc.
3.0
/
5.0
  |  1 reviews
A highly specific molecular test for early detection of cervical cancer. The HPV OncoTect™ E6, E7 mRNA Kit is a unique detection method that measures both the number of transforming cells and the quantity of E6, E7 mRNA in each cell. These two measurements precisely assess the overexpression of E6, E7 mRNA in routine patient samples collected in ThinPrep® and Surepath™ vials to further refine accuracy and specificity of HPV testing.Flow cytometry simplified: No requirement for extraction of... Read more


HPV OncoTect™ E6, E7 mRNA Kit by IncellDx, Inc. product image
HPV OncoTect™ E6, E7 mRNA Kit

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.




Average Rating: 3.0
1 Scientist has reviewed this product

4 out of 5
Ease of use
3 out of 5
After sales service
2 out of 5
Value for money


  • Status:

    Advanced Reviewer
  • Member since: 2012

  • Organization: Flow Cytometry-Research and Regenerative Medicine Department at IASO Hospital



  • Ease of use
    4 out of 5
    After sales service
    3 out of 5
    Value for money
    2 out of 5
Rating: 3.0

"The HPV OncoTect by incellDx is a detection kit for the HPV in E6, E7 mRNA level. This test is used in flow cytometry and is easy to use, could give reliable results and it could be a very promising alternative to the PCR detection of HPV."

Review date: 29 Sep 2014 | HPV OncoTect™ E6, E7 mRNA Kit
A highly specific molecular test for early detection of cervical cancer.

The HPV OncoTect™ E6, E7 mRNA Kit is a unique detection method that measures both the number of transforming cells and the quantity of E6, E7 mRNA in each cell. These two measurements precisely assess the overexpression of E6, E7 mRNA in routine patient samples collected in ThinPrep® and Surepath™ vials to further refine accuracy and specificity of HPV testing.


Flow cytometry simplified:

  • No requirement for extraction of nucleic acid, eliminating cross contamination
  • Results available in 3 hours for fast turnaround time
  • Variable batch sizes (24 or 96 specimens) for flexible throughput
  • Result output is clearly stated to indicate positive or negative
  • Adaptable to most flow cytometers

Clinical Performance:

  • Equivalent clinical sensitivity to HR HPV DNA Tests (95% detection of ≥ CIN2)
  • Significant increase in specificity
  • Unique specimen adequacy feature: 
    - Quantifies number of ectocervical and endocervical cells 
    - Quantifies the presence of obscuring inflammatory cells